Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marcelo A. Tinelli"'
Autor:
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, Marina Travacio, Ricardo Valentini, Daniel F. Alonso, Rubén Solari, Marcelo A. Tinelli, Rubén O. Cimino, Luis Álvarez, Pedro E. Fleitas, Laura Ceballos, Marcelo Golemba, Florencia Fernández, Diego Fernández de Oliveira, German Astudillo, Inés Baeck, Javier Farina, Georgina A. Cardama, Andrea Mangano, Eduardo Spitzer, Silvia Gold, Carlos Lanusse
Publikováno v:
EClinicalMedicine, Vol 39, Iss , Pp 101119- (2021)
Externí odkaz:
https://doaj.org/article/c1764cf40f3f4805a93edf70da908719
Autor:
Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, Marina Travacio, Ricardo Valentini, Daniel F. Alonso, Rubén Solari, Marcelo A. Tinelli, Rubén O. Cimino, Luis Álvarez, Pedro E. Fleitas, Laura Ceballos, Marcelo Golemba, Florencia Fernández, Diego Fernández de Oliveira, German Astudillo, Inés Baeck, Javier Farina, Georgina A. Cardama, Andrea Mangano, Eduardo Spitzer, Silvia Gold, Carlos Lanusse
Publikováno v:
EClinicalMedicine, Vol 37, Iss , Pp 100959- (2021)
Background: There are limited antiviral options for the treatment of patients with COVID-19. Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown potent activity against SARS-CoV-2 in vitro. This study aimed at asse
Externí odkaz:
https://doaj.org/article/42dbd47b55024b43afc025c81b6e6a77
Autor:
Luis Alvarez, German Astudillo, Adrian Luis Lifschitz, Florencia Facelli Fernández, Marcelo A. Tinelli, Georgina Alexandra Cardama, Javier Farina, Silvia Gold, Alejandro J. Krolewiecki, Carlos Edmundo Lanusse, Marcelo D. Golemba, Diego Fernández de Oliveira, Rubén O. Cimino, Ricardo Valentini, Marina Travacio, Laura Ceballos, Daniel F. Alonso, Inés Baeck, Matías Moragas, Pedro Emanuel Fleitas, Andrea Mangano, Rubén Solari, Eduardo Spitzer
Publikováno v:
EClinicalMedicine
EClinicalMedicine, Vol 37, Iss, Pp 100959-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
EClinicalMedicine, Vol 37, Iss, Pp 100959-(2021)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Background: There are limited antiviral options for the treatment of patients with COVID-19. Ivermectin (IVM), a macrocyclic lactone with a wide anti-parasitary spectrum, has shown potent activity against SARSCoV-2 in vitro. This study aimed at asses
Autor:
Rubén O. Cimino, Guthmann, Javier Farina, Silvia Gold, Marina Travacio, Laura Ceballos, Marcelo A. Tinelli, Daniel F. Alonso, Andrea Mangano, Adrian Luis Lifschitz, Carlos Edmundo Lanusse, Rubén Solari, Inés Baeck, Matías Moragas, Eduardo Spitzer, Alejandro J. Krolewiecki, Golemba, Pedro Emanuel Fleitas, Luis Alvarez, Oliveira DFd, German Astudillo, Florencia Facelli Fernández, Georgina Alexandra Cardama, Ricardo Valentini
Publikováno v:
SSRN Electronic Journal.
Background: There are limited antiviral options for the treatment of patients with coronavirus disease 2019 (COVID-19) that have demonstrated clinical efficacy and none of them is an oral drug. Ivermectin (IVM), a macrocytic lactone with a wide anti-
Autor:
Marcelo A. Tinelli, Marcelo D. Golemba, Carlos Edmundo Lanusse, Luis Alvarez, Alejandro J. Krolewiecki, Rubén O. Cimino, Rubén Solari, Georgina Alexandra Cardama, Adrian Luis Lifschitz, Daniel F. Alonso, Diego Fernández de Oliveira, Marina Travacio, Laura Ceballos, Florencia Facelli Fernández, Andrea Mangano, German Astudillo, Javier Farina, Silvia Gold, Ricardo Valentini, Inés Baeck, Matías Moragas, Pedro Emanuel Fleitas, Eduardo Spitzer
Publikováno v:
EClinicalMedicine, Vol 39, Iss, Pp 101119-(2021)
Autor:
Matias Ramirez Gismondi, Julio Manzitti, Daniel A. Benisek, Romina Quercia, Marcelo A. Tinelli, Andres M. Rousselot Ascarza, María Lourdes Scorsetti, Daniel H. Scorsetti, Maria Penna, Mateo A. Carpio Total, Amalia A. Ascarza, Francisco J. Fernández, Diego Gomez Rancaño, Eduardo Spitzer, Carola Lombas, Matías Deprati
Publikováno v:
Experimental and Therapeutic Medicine. 20:1-1
The present study was an open-label, prospective, uncontrolled and multicenter clinical trial to investigate the safety and effectiveness of bevacizumab (Lumiere®) administered by the intravitreal route for the treatment of neovascular age-related m